StockSelector.com
  Research, Select, & Monitor Sunday, October 20, 2019 5:42:17 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Gilead Sciences, Inc.$64.91($.32)(.49%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Gilead Sciences, Inc. has an overall rank of 150 out of 7004 stocks based on 16 positive rankings and 8 negative rankings.

Positive Rankings
Top Industry Values
Gilead Sciences rank is 20
Highest Cash Growth
Gilead Sciences rank is 87
Positive Guidance
Within the past 90 days Gilead Sciences has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 0.52%. Among companies that have had their estimates raised within the past month, Gilead Sciences is ranked 258.
Historic EPS Growth
Gilead Sciences rank is 297
Highest ROE
Gilead Sciences rank is 501
Target Prices
The average analysts' target price is $80.50 for Gilead Sciences using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Gilead Sciences is ranked 553.
Highest Net Margin
Gilead Sciences rank is 597
Highest ROA
Gilead Sciences rank is 805
Historic Revenue Growth
Gilead Sciences rank is 970
Estimated EPS Growth
Gilead Sciences rank is 1180
10 Day Gain
Gilead Sciences rank is 1191
Low Put/Call
Gilead Sciences has a low Put/Call ratio of 0.56 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Gilead Sciences is ranked 1276.
SSValue
The StockSelector Value for Gilead Sciences is $71.36. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Gilead Sciences is ranked 1303.
Estimated Revenue Growth
Gilead Sciences rank is 2009
Up EPS Surprise
Gilead Sciences beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Missed Whisper
According to EarningsWhispers.com, Gilead Sciences missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Gilead Sciences is ranked 124.
Price-to-Book
Gilead Sciences rank is 1153
Price-to-Sales
Gilead Sciences rank is 1361
Overbought Stochastics
Gilead Sciences rank is 1396
Debt-to-Equity
Gilead Sciences rank is 1663
90 Day Loss
Gilead Sciences rank is 1819
High vPut/Call
Gilead Sciences has a high Put/Call ratio of 0.58 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Gilead Sciences is ranked 1870.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.